参考文献 1.NCCN. Clinical Practice Guidelines in Oncology. Breast cancer, version 6.2024. Accessed November 21, 2024. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf 2.Novartis ribociclib (Kisqali®) recognized as...
NCCN 癌症治疗指南:子宫颈癌2024(英).pdf,NCCN GUIDELINES FOR PATIENTS® 2024 Cervical Cancer ® NATIONAL COMPREHENSIVE CANCER NETWORK Available online at Presented with support from FOUNDATION NCCN.org/patientguidelines Guiding Treatment. Changing L
参考文献: [1] Mette S. Van Ramshorst, Erik van Werkhoven, A phase III trial of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade for HER2+ breast cancer: The TRAIN-2 study (BOOG 2012-03).2017 ASCO abstract 507. [2] Qamar J. Khan, Colleen Bo...
2024 年第 2 版更新要点如下: DCIS-2、BINV-17、BINV-21、BINV-K 2/2 ►新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024....
2024 年第 2 版更新要点如下: DCIS-2、BINV-17、BINV-21、BINV-K 2/2 ►新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. ...
近日,美国国家综合癌症网络(NCCN)乳腺癌指南更新至2024年第1版,相较于前版,在乳腺癌药物治疗方面,新版指南聚焦于标准方案所联合使用的化疗方案上,对化疗药物的选择和剂量进行调整。 尤其针对不同类型乳腺癌患者,NCCN指南结合新近出炉的循证证据,对新...
womenwithclinicalT1-2N0M0breastcancer whohaveapositiveSN 165个研究者/177个研究机构 计划入组1900例患者(非劣效性研究) 提前关闭 Giuliano,etal,ASCO2010;Giuliano,etal,JAMA305:569,2011 入组/排除标准 入组标准排除标准 ·临床分期T1-2N0的乳腺癌·接受三野(包括淋巴结) 患者照射或部分乳腺加速照射 ·经HE染...
2024 年第 2 版更新要点如下: DCIS-2、BINV-17、BINV-21、BINV-K 2/2 ►新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. ...
[2] National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (2023 Version 3)[internet]; 2023. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf [3] 李帅萍. 三阴性乳腺癌患者辅助化疗后不同骨髓抑制程度对预后的影响[...
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 2.2024-Septemner 27, 2023. NCCN.org -Wood DE, Kazerooni EA, Aberle DR, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Lung Cancer Screening. Version 2.2024-October 18, 2023. NCCN.org ...